Entry Point Capital, LLC I Teos Therapeutics, Inc. Transaction History
Entry Point Capital, LLC
- $221 Million
- Q4 2024
A detailed history of Entry Point Capital, LLC transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 29,850 shares of ITOS stock, worth $214,323. This represents 0.1% of its overall portfolio holdings.
Number of Shares
29,850Holding current value
$214,323% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding ITOS
# of Institutions
160Shares Held
36.4MCall Options Held
1.95MPut Options Held
351K-
Black Rock Inc. New York, NY3.73MShares$26.8 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.18MShares$22.9 Million0.45% of portfolio
-
Boxer Capital, LLC San Diego, CA2.95MShares$21.2 Million1.6% of portfolio
-
Mpm Asset Management LLC Cambridge, MA2.74MShares$19.7 Million19.24% of portfolio
-
Tang Capital Management LLC San Diego, CA2.41MShares$17.3 Million2.09% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $255M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...